Compare JACK & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JACK | RPID |
|---|---|---|
| Founded | 1951 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.8M | 204.3M |
| IPO Year | 1994 | 2021 |
| Metric | JACK | RPID |
|---|---|---|
| Price | $11.73 | $2.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $21.93 | $8.00 |
| AVG Volume (30 Days) | ★ 969.6K | 221.8K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,465,314,000.00 | $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | $1.04 | $18.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $8.92 | $2.01 |
| 52 Week High | $27.74 | $4.94 |
| Indicator | JACK | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 45.83 | 39.39 |
| Support Level | $8.92 | $2.01 |
| Resistance Level | $20.96 | $2.43 |
| Average True Range (ATR) | 0.79 | 0.18 |
| MACD | 0.45 | 0.06 |
| Stochastic Oscillator | 81.24 | 62.22 |
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America. Its core business includes the Jack in the Box hamburger chain, known for a broad menu that features hamburgers, tacos, sandwiches, salads, and breakfast items. The company also operates the Del Taco brand, which offers a variety of both Mexican and American favorites such as burritos and fries. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.